OPCH Stock: Price, Forecast, Financials & AI Analysis

Loading...

01/14 14:28

OPCH Stock: Price, Forecast, Financials & AI Analysis

High

35.400

Open

34.700

VWAP

34.86

Vol

1.21M

Mkt Cap

5.52B

Low

34.590

Amount

42.14M

EV/EBITDA(TTM)

15.87

Total Shares

158.73M

EV

6.37B

EV/OCF(TTM)

24.62

P/S(TTM)

1.04

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.

Show More

Events Timeline

(ET)

2026-01-12

19:30:00

Tensions Between Fed and White House Impact Market Sentiment

2026-01-12

16:50:00

Company Board Approves Share Repurchase Program Increase to $1B

2026-01-12

16:50:00

Raises FY25 Revenue Outlook to $5.65B

2026-01-12

16:50:00

Sees FY26 Revenue $5.8B-$6B

2026-01-12

16:40:00

Sees Q4 Revenue of $1.46B-$1.47B

News

an image of Fool

PinnedOption Care Health (OPCH) Announces Preliminary Q4 2025 Results with $1.46B-$1.47B in Sales

an image of seekingalpha

02:44 AMseekingalpha

Option Care Health (OPCH) Reports Q4 Revenue of $1.46B and GAAP EPS of $0.37

an image of NASDAQ.COM

01:04 AMNASDAQ.COM

S&P 500 Index ($SPX) Declines 0.19% as Software Stocks Retreat

an image of NASDAQ.COM

01-13NASDAQ.COM

S&P 500, Dow, and Nasdaq Decline Amid Weakness in Tech Stocks

an image of CNBC

JPMorgan Chase Shares Drop Over 3% Amid Falling Investment Banking Fees

an image of Benzinga

Moderna Inc (MRNA) Projects $1.9 Billion Revenue for 2025, Shares Surge 12.8%

8 Analyst Rating

Wall Street analysts forecast OPCH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OPCH is 36.43 USD with a low forecast of 27.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

7 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

27.00

Averages

36.43

High

40.00

Current: 0.000

Low

27.00

Averages

36.43

High

40.00

Stephens

NULL -> Overweight

initiated

$40

Al Analysis

2025-12-10

Reason

Stephens

Price Target

$40

Al Analysis

2025-12-10

initiated

NULL -> Overweight

Reason

Stephens initiated coverage of Option Care Health with an Overweight rating and $40 price target.

Stephens

NULL -> Overweight

initiated

$40

2025-12-10

Reason

Stephens

Price Target

$40

2025-12-10

initiated

NULL -> Overweight

Reason

As previously reported, Stephens initiated coverage of Option Care Health with an Overweight rating and $40 price target. The company represents an established equity within the Healthcare Services universe underlying its leading, pure-play exposure to infusion services, the analyst tells investors in a research note. Option Care Health is well positioned in the value chain given its alternative-site/home-based orientation offering cost-bending benefits, while structurally exhibiting a premium organic growth baseline vs. traditional settings, the firm added.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for OPCH

Unlock Now

Valuation Metrics

The current forward P/E ratio for Option Care Health Inc (OPCH.O) is 21.79, compared to its 5-year average forward P/E of 27.64. For a more detailed relative valuation and DCF analysis to assess Option Care Health Inc 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

an image of dotted line Image

5Y Average PE

27.64

Current PE

21.79

Overvalued PE

33.07

Undervalued PE

22.20

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

an image of dotted line Image

5Y Average EV/EBITDA

15.28

Current EV/EBITDA

12.49

Overvalued EV/EBITDA

17.89

Undervalued EV/EBITDA

12.67

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

an image of dotted line Image

5Y Average PS

1.13

Current PS

0.86

Overvalued PS

1.32

Undervalued PS

0.93

Financials

Al Analysis

Annual

Quarterly

Trading Trends

People Also Watch

Frequently Asked Questions

What is Option Care Health Inc (OPCH) stock price today?

The current price of OPCH is 35.07 USD — it has increased 0.92 % in the last trading day.

What is Option Care Health Inc (OPCH)'s business?

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.

What is the price predicton of OPCH Stock?

Wall Street analysts forecast OPCH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OPCH is36.43 USD with a low forecast of 27.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Option Care Health Inc (OPCH)'s revenue for the last quarter?

Option Care Health Inc revenue for the last quarter amounts to 1.44B USD, increased 12.24 % YoY.

What is Option Care Health Inc (OPCH)'s earnings per share (EPS) for the last quarter?

Option Care Health Inc. EPS for the last quarter amounts to 0.32 USD, increased 3.23 % YoY.

How many employees does Option Care Health Inc (OPCH). have?

Option Care Health Inc (OPCH) has 6015 emplpoyees as of January 14 2026.

What is Option Care Health Inc (OPCH) market cap?

Today OPCH has the market capitalization of 5.52B USD.